Sanford Burnham Prebys Medical Discovery Institute-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sanford Burnham Prebys Medical Discovery Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013365
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanford Burnham Prebys Medical Discovery Institute (Sanford Burnham) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microenvironment and cancer immunology, degenerative diseases, immunity and pathogenesis, human genetics development, aging and regeneration, bioinformatics and structural biology, cardiovascular metabolism, integrative metabolism, and genomic control of metabolism. It offers stem cell research and drug discovery technologies. The institute’s technology centers include conrad prebys center for chemical genomics, stem cell research center and translational research institute, among others. It operates in La Jolla and Orlando, the US. Sanford-Burnham is headquartered in La Jolla, California, the US.

Sanford Burnham Prebys Medical Discovery Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Takeda Pharma Enters into Agreement with Sanford-Burnham 11
Eli Lilly to Enter into Research Agreement with Sanford Burnham 12
Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13
Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15
Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16
Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17
Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 18
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 19
Sanford-Burnham Medical Research Institute Enters Into Agreement With Pfizer 20
Sanford-Burnham Medical Enters Into Collaboration With Ortho-McNeil-Janssen Pharma 21
Licensing Agreements 22
Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22
Clementia Pharma to Enter into License Agreement with Sanford Burnham Prebys Medical 23
EnduRx Pharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24
Sanford Burnham Prebys Medical Discovery Institute – Key Competitors 25
Sanford Burnham Prebys Medical Discovery Institute – Key Employees 26
Sanford Burnham Prebys Medical Discovery Institute – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Government and Public Interest 28
Sep 26, 2017: SBP scientist receives $10.8 million grant to advance potential drug for substance abuse 28
Aug 08, 2016: Scientists discover potential avenue to treating type 2 diabetes at early stages 29
May 06, 2016: Researchers Find a Way to Deliver Drugs to the Placenta to Support Healthier Pregnancies 30
Feb 17, 2016: Researchers Reveal New Links Between Heart Hormones Obesity and Diabetes 31
Product News 32
Mar 14, 2016: New drug combination shows promise against childhood brain cancer 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Key Facts 2
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sanford Burnham Prebys Medical Discovery Institute, Deals By Therapy Area, 2011 to YTD 2017 8
Sanford Burnham Prebys Medical Discovery Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Takeda Pharma Enters into Agreement with Sanford-Burnham 11
Eli Lilly to Enter into Research Agreement with Sanford Burnham 12
Sanford Burnham Enters into Co-Development Agreement with Daiichi Sankyo 13
Sanford-Burnham Medical Research Institute Enters Into Research Agreement With Pfizer 14
Mayo Clinic Enters Into Research Agreement With Sanford-Burnham Medical Research Institute 15
Sanford Burnham Enters into Agreement With 60 Degrees Pharma 16
Sanford-Burnham And Florida Hospital Extend Research Agreement With Takeda 17
Sanford-Burnham Medical Enters Into Agreement With Intrexon For Stem Cell Research 18
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 19
Sanford-Burnham Medical Research Institute Enters Into Agreement With Pfizer 20
Sanford-Burnham Medical Enters Into Collaboration With Ortho-McNeil-Janssen Pharma 21
Tarrex Biopharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 22
Clementia Pharma to Enter into License Agreement with Sanford Burnham Prebys Medical 23
EnduRx Pharma Enters into Licensing Agreement with Sanford Burnham Prebys Medical Discovery Institute 24
Sanford Burnham Prebys Medical Discovery Institute, Key Competitors 25
Sanford Burnham Prebys Medical Discovery Institute, Key Employees 26
Sanford Burnham Prebys Medical Discovery Institute, Other Locations 27

★海外企業調査レポート[Sanford Burnham Prebys Medical Discovery Institute-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cherry Rocher Neyret Chavin SA:企業の戦略・SWOT・財務情報
    Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report Summary Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • VentiRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary VentiRx Pharmaceuticals Inc (VentiRx) is a biopharmaceutical company that develops and commercializes drugs for the treatment of respiratory, autoimmune diseases and cancer. The company develops toll like receptor 8 agonist and antagonists for the treatment of cancer, respiratory and autoimm …
  • Lydall Inc (LDL):企業の財務・戦略的SWOT分析
    Lydall Inc (LDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Curtiss-Wright Corp (CW):電力:M&Aディール及び事業提携情報
    Summary Curtiss-Wright Corp (Curtiss-Wright) is a manufacturing and service company. It designs, manufactures, and overhauls precision components and provides highly engineered critical function products. The company also provides support services for critical applications. Curtiss-Wright serves cus …
  • SRP Groupe SA (SRP):企業の財務・戦略的SWOT分析
    SRP Groupe SA (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Piramal Enterprises Ltd (PEL):医療機器:M&Aディール及び事業提携情報
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • DTEK Energy B.V.:電力:M&Aディール及び事業提携情報
    Summary DTEK Energy B.V. (DTEK Energy), formerly DTEK Holdings B.V., is a vertically-integrated utility that conducts coal mining and processing; electricity generation; manufacture of mining machinery; trading of coal and electricity in Ukrainian and international markets; and repair and maintenanc …
  • NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析
    Summary NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bir …
  • Calypso Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Calypso Biotech SA (Calypso) is a biopharmaceutical company that develops antibody therapies. The company provides pipeline products such as CALY-0001 and CALY-0002. Its CALY-0001 therapeutic antibody is used in the treatment of Crohn’s disease; and CALY-0002 a humanized monoclonal antibody …
  • EPS Holdings Inc (4282):製薬・医療:M&Aディール及び事業提携情報
    Summary EPS Holdings Inc (EPS) is a pharmaceutical solutions provider to the healthcare industry. The company provides contract research organization, site management organization, contract sales organization, and other related services for pharmaceutical and medical device development. Its services …
  • BayWa AG:戦略・SWOT・企業財務分析
    BayWa AG - Strategy, SWOT and Corporate Finance Report Summary BayWa AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Yifan Pharmaceutical Co.,Ltd:企業の戦略・SWOT・財務情報
    Yifan Pharmaceutical Co.,Ltd - Strategy, SWOT and Corporate Finance Report Summary Yifan Pharmaceutical Co.,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sui Northern Gas Pipelines Ltd (SNGP):企業の財務・戦略的SWOT分析
    Sui Northern Gas Pipelines Ltd (SNGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Lawson Inc:企業の戦略・SWOT・財務分析
    Lawson Inc - Strategy, SWOT and Corporate Finance Report Summary Lawson Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Avenue Supermarts Limited (DMART):企業の財務・戦略的SWOT分析
    Avenue Supermarts Limited (DMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Electricidade de Mocambique EP:企業の戦略的SWOT分析
    Electricidade de Mocambique EP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Orion New Zealand Ltd:企業の戦略的SWOT分析
    Orion New Zealand Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Steel Authority of India Ltd:戦略・SWOT・企業財務分析
    Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hamilton Thorne Ltd (HTL):企業の財務・戦略的SWOT分析
    Summary Hamilton Thorne Ltd (Hamilton Thorne) is a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm …
  • Haier Electronics Group Co Ltd:企業の戦略・SWOT・財務情報
    Haier Electronics Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Haier Electronics Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆